×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Ii Robert Goeltz


Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerMay 11, 2026Sale$25.637,763198,96684,161May 12, 2026, 04:09 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 31, 2025Sale$23.386,552153,18667,924Jan 02, 2026, 04:19 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 16, 2025Sale$21.886,702146,66980,436Dec 18, 2025, 05:35 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 17, 2025Sale$22.165,960132,07174,476Dec 18, 2025, 05:35 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerNov 26, 2025Sale$25.005,000125,00087,138Nov 26, 2025, 04:07 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerOct 28, 2025Sale$20.005,000100,00092,138Oct 29, 2025, 08:54 AM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 15, 2024Tax Payment (Shares)$16.0810,099162,39263,732Dec 17, 2024, 08:36 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerJan 02, 2024Sale$20.002,00440,08051,831Jan 04, 2024, 05:23 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 19, 2023Disposition to Issuer$18.092,80850,79753,835Dec 20, 2023, 04:10 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 18, 2023Disposition to Issuer$17.742,74948,76756,643Dec 20, 2023, 04:10 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerJun 07, 2023Sale$20.044,04981,14259,392Jun 09, 2023, 04:05 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 16, 2022Sale$30.752,45375,43011,953Dec 16, 2022, 09:44 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 16, 2021Sale$39.8348519,3157,771Dec 20, 2021, 04:22 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerDec 17, 2021Sale$40.3662125,0617,502Dec 20, 2021, 04:22 PM
RCUSArcus Biosciences, Inc.Ii Robert GoeltzChief Financial OfficerSep 09, 2020Buy$21.575,000107,8495,000Sep 09, 2020, 04:53 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerMay 12, 2017Option/RSU Exercise$5.5419,967110,70032,756May 16, 2017, 04:57 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerApr 10, 2017Option/RSU Exercise$4.473,00013,41812,789Apr 11, 2017, 12:51 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerMar 20, 2017Option/RSU Exercise$4.4721,51796,24131,306Mar 21, 2017, 06:05 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerMar 20, 2017Sale$19.8121,517426,34021,306Mar 21, 2017, 06:05 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerMar 09, 2017Option/RSU Exercise$4.472,50011,1829,789Mar 09, 2017, 07:22 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerNov 30, 2016Award/Grant$9.101,28911,7237,289Dec 01, 2016, 07:01 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerSep 29, 2016Option/RSU Exercise$4.474,00017,8916,000Oct 03, 2016, 02:32 PM
CTMXCytomX Therapeutics, Inc.Ii Robert GoeltzChief Financial OfficerMay 12, 2016Option/RSU Exercise$4.472,0008,9462,000May 13, 2016, 04:05 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe